Dimensional Fund Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $396M | Buy |
513,060
+13,516
| +3% | +$10.3M | 0.08% | 235 |
|
|
2025
Q4 | $386M | Buy |
499,544
+448
| +0.1% | +$304K | 0.08% | 232 |
|
|
2025
Q3 | $281M | Sell |
499,096
-20,341
| -4% | -$11.5M | 0.06% | 366 |
|
|
2025
Q2 | $273M | Sell |
519,437
-51,750
| -9% | -$28.9M | 0.06% | 342 |
|
|
2025
Q1 | $362M | Sell |
571,187
-15,838
| -3% | -$10.9M | 0.09% | 198 |
|
|
2024
Q4 | $418M | Buy |
587,025
+16,961
| +3% | +$14.2M | 0.1% | 155 |
|
|
2024
Q3 | $599M | Sell |
570,064
-16,498
| -3% | -$18.4M | 0.15% | 92 |
|
|
2024
Q2 | $616M | Sell |
586,562
-2,391
| -0.4% | -$2.32M | 0.16% | 85 |
|
|
2024
Q1 | $567M | Sell |
588,953
-4,569
| -0.8% | -$4.34M | 0.15% | 97 |
|
|
2023
Q4 | $521M | Sell |
593,522
-25,744
| -4% | -$21.2M | 0.15% | 91 |
|
|
2023
Q3 | $510M | Buy |
619,266
+6,442
| +1% | +$5.06M | 0.17% | 81 |
|
|
2023
Q2 | $440M | Sell |
612,824
-20,684
| -3% | -$15.9M | 0.14% | 109 |
|
|
2023
Q1 | $520M | Sell |
633,508
-1,080
| -0.2% | -$815K | 0.18% | 77 |
|
|
2022
Q4 | $458K | Sell |
634,588
-15,819
| -2% | -$11.7M | 0.14% | 95 |
|
|
2022
Q3 | $448M | Buy |
650,407
+18,501
| +3% | +$11.6M | 0.17% | 77 |
|
|
2022
Q2 | $374M | Buy |
631,906
+46,757
| +8% | +$30.4M | 0.13% | 118 |
|
|
2022
Q1 | $409M | Buy |
585,149
+82,651
| +16% | +$52.3M | 0.13% | 125 |
|
|
2021
Q4 | $317M | Buy |
502,498
+98,968
| +25% | +$60.8M | 0.1% | 186 |
|
|
2021
Q3 | $244M | Buy |
403,530
+83,276
| +26% | +$51.7M | 0.08% | 249 |
|
|
2021
Q2 | $179M | Buy |
320,254
+70,107
| +28% | +$35.5M | 0.06% | 408 |
|
|
2021
Q1 | $118M | Buy |
250,147
+13,304
| +6% | +$6.48M | 0.04% | 683 |
|
|
2020
Q4 | $114M | Buy |
236,843
+11,978
| +5% | +$6.47M | 0.04% | 632 |
|
|
2020
Q3 | $126M | Buy |
224,865
+8,460
| +4% | +$5.13M | 0.05% | 419 |
|
|
2020
Q2 | $135M | Buy |
216,405
+7,195
| +3% | +$4.08M | 0.06% | 350 |
|
|
2020
Q1 | $102M | Buy |
209,210
+2,510
| +1% | +$1.04M | 0.05% | 401 |
|
|
2019
Q4 | $77.6M | Sell |
206,700
-2,192
| -1% | -$737K | 0.03% | 976 |
|
|
2019
Q3 | $57.9M | Buy |
208,892
+12,301
| +6% | +$3.64M | 0.02% | 1253 |
|
|
2019
Q2 | $61.5M | Buy |
196,591
+16,960
| +9% | +$5.65M | 0.02% | 1197 |
|
|
2019
Q1 | $73.8M | Sell |
179,631
-3,806
| -2% | -$1.57M | 0.03% | 955 |
|
|
2018
Q4 | $68.5M | Buy |
183,437
+5,971
| +3% | +$2.19M | 0.03% | 901 |
|
|
2018
Q3 | $71.7M | Buy |
177,466
+5,605
| +3% | +$2.13M | 0.03% | 1042 |
|
|
2018
Q2 | $59.3M | Buy |
171,861
+2,191
| +1% | +$685K | 0.02% | 1228 |
|
|
2018
Q1 | $58.4M | Buy |
169,670
+2,053
| +1% | +$714K | 0.02% | 1164 |
|
|
2017
Q4 | $63M | Buy |
167,617
+6,126
| +4% | +$2.48M | 0.03% | 1086 |
|
|
2017
Q3 | $72.2M | Buy |
161,491
+633
| +0.4% | +$301K | 0.03% | 873 |
|
|
2017
Q2 | $79M | Buy |
160,858
+1,564
| +1% | +$684K | 0.04% | 725 |
|
|
2017
Q1 | $61.7M | Buy |
159,294
+4,039
| +3% | +$1.5M | 0.03% | 931 |
|
|
2016
Q4 | $57M | Sell |
155,255
-900
| -0.6% | -$342K | 0.03% | 991 |
|
|
2016
Q3 | $62.8M | Buy |
156,155
+14,767
| +10% | +$5.92M | 0.03% | 798 |
|
|
2016
Q2 | $49.4M | Buy |
141,388
+415
| +0.3% | +$160K | 0.03% | 993 |
|
|
2016
Q1 | $50.8M | Buy |
140,973
+4,526
| +3% | +$1.87M | 0.03% | 905 |
|
|
2015
Q4 | $74.1M | Buy |
136,447
+7,316
| +6% | +$3.96M | 0.05% | 522 |
|
|
2015
Q3 | $60.1M | Buy |
129,131
+1,926
| +2% | +$1.03M | 0.04% | 641 |
|
|
2015
Q2 | $64.9M | Buy |
127,205
+5,032
| +4% | +$2.46M | 0.04% | 637 |
|
|
2015
Q1 | $55.2M | Buy |
122,173
+1,008
| +0.8% | +$427K | 0.03% | 744 |
|
|
2014
Q4 | $49.7M | Buy |
121,165
+6,226
| +5% | +$2.45M | 0.03% | 758 |
|
|
2014
Q3 | $41.4M | Sell |
114,939
-14,276
| -11% | -$4.78M | 0.03% | 848 |
|
|
2014
Q2 | $36.5M | Buy |
129,215
+906
| +0.7% | +$269K | 0.03% | 1000 |
|
|
2014
Q1 | $38.5M | Buy |
128,309
+847
| +0.7% | +$261K | 0.03% | 867 |
|
|
2013
Q4 | $35.1M | Sell |
127,462
-300
| -0.2% | -$86.3K | 0.03% | 914 |
|
|
2013
Q3 | $40M | Buy |
127,762
+1,006
| +0.8% | +$265K | 0.03% | 698 |
|
|
2013
Q2 | $28.5M | Buy |
+126,756
| New | +$29.5M | 0.03% | 900 |
|
Other funds holding REGN
VCM
N
Dimensional Fund Advisors's REGN Position: Q1 2026 in Review
Dimensional Fund Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 2.7% in Q1 2026, buying an estimated $10.3M and bringing the position to 513,060 shares worth $396M. The position accounts for 0.08% of the portfolio, ranked #235.
Dimensional Fund Advisors first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $616M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Dimensional Fund Advisors held 513,060 shares of Regeneron Pharmaceuticals worth $396M as of Q1 2026.
- Dimensional Fund Advisors bought 13,516 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $10.3M.
- Regeneron Pharmaceuticals made up 0.08% of Dimensional Fund Advisors's portfolio in Q1 2026, its #235 holding.
- Dimensional Fund Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Dimensional Fund Advisors's Regeneron Pharmaceuticals position peaked at $616M in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.